BELANTAMAB MAFODOTIN
| Drug Type | Action Type | Mechanism of Action | Approved | Max Trial Phase | Max GBM Phase |
|---|---|---|---|---|---|
| Antibody | BINDING AGENT | Tumor necrosis factor receptor superfamily member 17 binding agent | no | 4 | 0 |
| Drug Type | Action Type | Mechanism of Action | Approved | Max Trial Phase | Max GBM Phase |
|---|---|---|---|---|---|
| Antibody | BINDING AGENT | Tumor necrosis factor receptor superfamily member 17 binding agent | no | 4 | 0 |